Esperion Therapeutics, Inc. (NASDAQ:ESPR) appears in 195 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 2,848,410 | 19.20% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 2,853,005 | 23.59% | $0.00 |
| Two Seas Capital LP | 31 Dec, 2025 | 0 | 2,152,797 | 22.08% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -201,941 | -31.30% | $0.00 |
| WASATCH ADVISORS LP | 31 Dec, 2025 | 0 | 2,383,902 | 33.76% | $0.00 |
| PenderFund Capital Management Ltd. | 31 Dec, 2025 | 0 | -2,284,593 | -34.22% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 37,020 | 0.00% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 6,694,850 | 3,208.91% | $0.00 |
| AIGH Capital Management LLC | 31 Dec, 2025 | 0 | 1,000,000 | 33.33% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,440 | 0.00% | $0.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 0 | 5,965,498 | 0.00% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | 3,851,133 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,451,462 | 32.41% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -98,956 | -2.67% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 986,255 | 20.76% | $0.00 |
| Walleye Capital LLC | 31 Dec, 2025 | 0 | 1,250,025 | 391.62% | $0.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 0 | 2,950,172 | 117.00% | $0.00 |
| Velan Capital Investment Management LP | 31 Dec, 2025 | 0 | 1,210,000 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 2,503,464 | 111.83% | $0.00 |
| Burkehill Global Management, LP | 31 Dec, 2025 | 0 | 400,000 | 0.00% | $0.00 |